Compared with the growth of D5 tumor implants in the control mice, the growth of D5 tumor implants in the cured mice treated with an anti-VEGFA activity (G6.31.2a alone, G6.31.2a plus 4D5.2a, or TG-VHS) was remarkably slower (Figure 6C). The gene discussed is VEGFA; the disease is neoplasm.